AyuVis: Funding, Investors & Team (Oct 2026)
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.
AyuVis has raised $3.9M across 2 funding rounds on record, the most recent an undisclosed round of $2.1M announced in May 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AyuVis Company Profile and Key Stats
Latest funding round on record: May 2023.
AyuVis Funding Rounds
AyuVis raised $1.8M in a Grant announced in May 2022.
1 years later, an undisclosed round of $2.1M was announced in May 2023.
AyuVis Founders and Leadership Team
Contact details for the AyuVis team: 2 of 2 have an email address on file.
Start 14-day free trial →AyuVis Funding Compared to Other Biotechnology Startups
AyuVis' latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AyuVis in Biotechnology and Fort Worth
Companies Similar to AyuVis
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
AyuVis Funding FAQs
What does AyuVis do?
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.
How much funding has AyuVis raised?
AyuVis has raised $3.9M across 2 rounds on record. The most recent is an undisclosed round of $2.1M announced in May 2023.
When did AyuVis last raise funding?
AyuVis' most recent funding round on record is an undisclosed round of $2.1M, announced in May 2023.
Who founded AyuVis?
FundedIQ lists Gagan Acharya (Founder) at AyuVis.
Who is the CEO of AyuVis?
Suchismita Acharya is listed as CEO at AyuVis.
Where is AyuVis headquartered?
AyuVis is based in Fort Worth, Texas, United States.
How many employees does AyuVis have?
AyuVis is in the 1-10 employee band.
How does AyuVis' funding compare to other Biotechnology startups?
AyuVis' latest round of $2.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AyuVis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AyuVis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.